Vonetize Plc: Update regarding the sale of the controlling shareholders’ shares to US based Desilu Studios Inc.; target price unchanged at NIS 1.43 Post author:jaimeuss_admin Post published:17 בSeptember 2018 Post category:Research Continue ReadingVonetize Plc: Update regarding the sale of the controlling shareholders’ shares to US based Desilu Studios Inc.; target price unchanged at NIS 1.43
Brainsway Ltd: The company’s main competitor has completed an IPO, providing for a new benchmark to Brainsway’s valuation; target price unchanged. Post author:jaimeuss_admin Post published:17 בSeptember 2018 Post category:Research Continue ReadingBrainsway Ltd: The company’s main competitor has completed an IPO, providing for a new benchmark to Brainsway’s valuation; target price unchanged.
RedHill Biopharma Ltd.: The acceleration of RHB-104 Phase III Study in Crohn’s disease increases company value and share price. Post author:jaimeuss_admin Post published:17 בSeptember 2018 Post category:Research Continue ReadingRedHill Biopharma Ltd.: The acceleration of RHB-104 Phase III Study in Crohn’s disease increases company value and share price.
RedHill Biopharma announces positive top-line results from Phase III study of RHB-104 in Crohn’s Disease; remission rates at week-52 are low by market comparison; Redhill plans to raise additional capital to support future clinical development; target price remains at NIS 2.59 Post author:jaimeuss_admin Post published:16 בSeptember 2018 Post category:Research Continue ReadingRedHill Biopharma announces positive top-line results from Phase III study of RHB-104 in Crohn’s Disease; remission rates at week-52 are low by market comparison; Redhill plans to raise additional capital to support future clinical development; target price remains at NIS 2.59
Enlight Renewable Energy Ltd: Significant regualtory progress brings Enlight closer to final-stage approvals for the Bereshit wind farm; stock target price unchanged. Post author:jaimeuss_admin Post published:6 בSeptember 2018 Post category:Research Continue ReadingEnlight Renewable Energy Ltd: Significant regualtory progress brings Enlight closer to final-stage approvals for the Bereshit wind farm; stock target price unchanged.
Entera Bio Ltd., a subsidiary of DNA Biomedical Solutions Ltd. has announced the share pricing for its forthcoming IPO (Nasdaq); As pricing was at similar valuation to our initiation report, target price remains unchanged. Post author:jaimeuss_admin Post published:30 בAugust 2018 Post category:Research Continue ReadingEntera Bio Ltd., a subsidiary of DNA Biomedical Solutions Ltd. has announced the share pricing for its forthcoming IPO (Nasdaq); As pricing was at similar valuation to our initiation report, target price remains unchanged.
BioLineRx Ltd.: Additional Investment by A Principal Investor Reflects a Confidence in the Company. Target Price Unchanged Post author:jaimeuss_admin Post published:30 בAugust 2018 Post category:Research Continue ReadingBioLineRx Ltd.: Additional Investment by A Principal Investor Reflects a Confidence in the Company. Target Price Unchanged
